Inflammasome Activation Linked to Cisplatin Resistance in Ovarian Cancer
Recent studies have shed light on a troubling phenomenon in the realm of ovarian cancer treatment—the observed resistance of tumors to cisplatin, a cornerstone chemotherapeutic...
















